Archives 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 December 24, 2021 TR1 – Lanstead – Major Holding in Shares Read More December 20, 2021 Subscriptions and Placing to raise £3.55 million; Sharing Agreement; to fund Investment in R&D pipeline • Company’s Partner Alora and two longstanding investors including Lanstead to participate at an Issue price of 11p – 80% premium to current share price Read More November 29, 2021 Collaboration with Imperial College London Read More November 18, 2021 CORPORATE UPDATE – The Evolution of ImmuPharma Read More October 01, 2021 EURONEXT DELISTING – Date: 18 October 2021 Read More September 30, 2021 Prof. Sylviane Muller awarded prestigious Legion d’honneur.’ Read More September 29, 2021 Corporate Update Read More September 29, 2021 INTERIM RESULTS ANNOUNCEMENT for the six months ended 30 June 2021 Read More August 24, 2021 Director & PDMR Share Purchases Read More August 17, 2021 Lanstead Capital TR1 Read More August 12, 2021 FDA approves the Lupzuor™ PK study Read More July 30, 2021 BOARD CHANGES Read More 12
December 20, 2021 Subscriptions and Placing to raise £3.55 million; Sharing Agreement; to fund Investment in R&D pipeline • Company’s Partner Alora and two longstanding investors including Lanstead to participate at an Issue price of 11p – 80% premium to current share price Read More
